[Infant feeding practice and later obesity risk. Indications for early metabolic programming]

B Koletzko1, S Schiess, B Brands

  • 1Abt. Stoffwechsel- und Ernährungsmedizin, Dr. von Haunersches Kinderspital, Klinikum der Ludwig-Maximilians-Universität München, Lindwurmstr. 4, 80337, München, Deutschland. office.koletzko@med.uni-muenchen.de

Insights

Early infant feeding significantly impacts long-term health. Lower protein infant formula normalized growth, potentially protecting against later obesity, unlike higher protein formulas.

Area of Science:

  • Developmental biology
  • Nutritional science
  • Public health

Background:

  • Early metabolic programming links developmental nutrition to long-term health outcomes, including obesity.
  • Observational studies suggest breastfeeding reduces later obesity risk compared to formula feeding.
  • The 'early protein hypothesis' posits lower protein in human milk protects against infant overgrowth and subsequent obesity.

Purpose of the Study:

  • To test the 'early protein hypothesis' regarding infant formula composition and long-term obesity risk.
  • To evaluate the impact of reduced protein content in infant formula on early growth patterns.
  • To assess the potential of infant feeding practices for long-term health programming.

Main Methods:

  • A double-blind, randomized clinical trial (European Childhood Obesity Project) involving 1,678 infants across five European countries.
  • Infants were randomized to receive either higher or lower protein content infant and follow-on formulas for the first year.
  • Follow-up data collected at age 2 years, comparing growth to breastfed infants and WHO standards.

Main Results:

  • Infant formula with reduced protein content normalized early growth trajectories.
  • Growth patterns in the reduced protein group aligned with a breastfed reference group and WHO growth standards.
  • This normalization suggests a potential for long-term protection against later obesity.

Conclusions:

  • Infant feeding practices, specifically formula composition, significantly influence long-term health.
  • Reduced protein formulas demonstrate potential for preventing early excessive weight gain and mitigating future obesity risk.
  • Findings support a review of current infant formula recommendations and policies to optimize infant health outcomes.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...